ResearcherKaohsiung Medical UniversityActive in the last 2 years
Hui‐Ching Wang
Matched on ORCID iD 0000-0002-8232-0387; OpenAlex author ID A5089886091, A5113915429. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Exploring the characteristics of the SKP2-CDK6 axis in pancreatic cancer cell metastasis and its clinical significance. Co-author DOI 10.1016/j.yexmp.2026.105024↗
- Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer. Co-author DOI 10.7150/ijms.73800↗
- Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-cente… Co-author DOI 10.1371/journal.pone.0244487↗
- Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer. First author PMID 30323973↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Li‐Tzong Chen · 3 shared papers, 2020–2026 · strength 0.52
- Paper Exploring the characteristics of the SKP2-CDK6 axis in pancreatic cancer cell metastasis and its clinical significance. DOI 10.1016/j.yexmp.2026.105024↗
- Paper Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreati… DOI 10.7150/ijms.73800↗
- Paper Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic … DOI 10.1371/journal.pone.0244487↗
- Mei‐Ren Pan · 3 shared papers, 2018–2026 · strength 0.48
- Paper Exploring the characteristics of the SKP2-CDK6 axis in pancreatic cancer cell metastasis and its clinical significance. DOI 10.1016/j.yexmp.2026.105024↗
- Paper Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreati… DOI 10.7150/ijms.73800↗
- Paper Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cance… PMID 30323973↗
- Yung‐Yeh Su · 2 shared papers, 2020–2022 · strength 0.26
- Paper Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreati… DOI 10.7150/ijms.73800↗
- Paper Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic … DOI 10.1371/journal.pone.0244487↗
- Nai‐Jung Chiang · 1 shared paper, 2020 · strength 0.12
- Chia‐Yu Chen · 1 shared paper, 2020 · strength 0.12
- Li‐Yuan Bai · 1 shared paper, 2020 · strength 0.12
- Yufeng Tian · 1 shared paper, 2018 · strength 0.08
- Wen‐Chun Hung · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.